BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17587186)

  • 21. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression.
    Hajizadeh F; Moghadaszadeh Ardebili S; Baghi Moornani M; Masjedi A; Atyabi F; Kiani M; Namdar A; Karpisheh V; Izadi S; Baradaran B; Azizi G; Ghalamfarsa G; Sabz G; Yousefi M; Jadidi-Niaragh F
    Eur J Pharmacol; 2020 Sep; 882():173235. PubMed ID: 32574672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.
    Stagg J; Divisekera U; McLaughlin N; Sharkey J; Pommey S; Denoyer D; Dwyer KM; Smyth MJ
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1547-52. PubMed ID: 20080644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells.
    Kang H; Ko J; Jang SW
    Biochem Biophys Res Commun; 2012 Jun; 423(1):188-94. PubMed ID: 22640735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo.
    Koszałka P; Pryszlak A; Gołuńska M; Kolasa J; Stasiłojć G; Składanowski AC; Bigda JJ
    Oncol Rep; 2014 Feb; 31(2):819-27. PubMed ID: 24297662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma.
    Shali S; Yu J; Zhang X; Wang X; Jin Y; Su M; Liao X; Yu J; Zhi X; Zhou P
    J Cell Physiol; 2019 Jul; 234(7):10248-10259. PubMed ID: 30417547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer.
    Petruk N; Tuominen S; Åkerfelt M; Mattsson J; Sandholm J; Nees M; Yegutkin GG; Jukkola A; Tuomela J; Selander KS
    Sci Rep; 2021 Mar; 11(1):6035. PubMed ID: 33727591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of SiRNA-EGFR on the expression of hyaluronidase gene EGFR in human breast cancer cells].
    Wu WD; Fang CH; Yang ZX; Bao JJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1260-3. PubMed ID: 20584652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and characterization of CD73-siRNA-loaded nanoemulsion: effect on C6 glioma cells and primary astrocytes.
    Teixeira FC; Bruxel F; Azambuja JH; Berenguer AM; Stefani MA; Sévigny J; Spanevello RM; Battastini AMO; Teixeira HF; Braganhol E
    Pharm Dev Technol; 2020 Apr; 25(4):408-415. PubMed ID: 31847658
    [No Abstract]   [Full Text] [Related]  

  • 30. Indomethacin stimulates activity and expression of ecto-5'-nucleotidase/CD73 in glioma cell lines.
    Bernardi A; Bavaresco L; Wink MR; Jacques-Silva MC; Delgado-Cañedo A; Lenz G; Battastini AM
    Eur J Pharmacol; 2007 Aug; 569(1-2):8-15. PubMed ID: 17568578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy.
    Qiao Z; Li X; Kang N; Yang Y; Chen C; Wu T; Zhao M; Liu Y; Ji X
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
    Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
    Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells.
    Quezada C; Garrido W; Oyarzún C; Fernández K; Segura R; Melo R; Casanello P; Sobrevia L; San Martín R
    J Cell Physiol; 2013 Mar; 228(3):602-8. PubMed ID: 22833450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BMP-6 inhibits the metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
    Hu F; Zhang Y; Li M; Zhao L; Chen J; Yang S; Zhang X
    Oncol Rep; 2016 Mar; 35(3):1823-30. PubMed ID: 26751737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
    Wang L; Wang X; Liang Y; Diao X; Chen Q
    Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.
    Yang J; Wang R; Li H; Lv Q; Meng W; Yang X
    Cancer Biomark; 2016 Jul; 17(2):237-47. PubMed ID: 27434292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3K/AKT and NF-κB signaling pathways.
    Leung HW; Wang Z; Yue GG; Zhao SM; Lee JK; Fung KP; Leung PC; Lau CB; Tan NH
    Biochim Biophys Acta; 2015 Aug; 1853(8):1827-40. PubMed ID: 25953046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ecto-5'-nucleotidase activity is not required for T cell activation through CD73.
    Gutensohn W; Resta R; Misumi Y; Ikehara Y; Thompson LF
    Cell Immunol; 1995 Apr; 161(2):213-7. PubMed ID: 7697732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
    Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
    Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.